115 related articles for article (PubMed ID: 24422411)
1. [Pharmacokinetics of scutellarin and its derivant scutellarin ethyl ester in rats].
Zhu LW; Liu XQ; Feng J; Gao HM; Yi H; Wang ZM; Meng QJ
Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(19):3373-7. PubMed ID: 24422411
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic and tissue distribution study of scutellarin in rats].
You HS; Dong YL; Xing JF; Zhang CL; Wang MY
Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1688-92. PubMed ID: 18027669
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs of scutellarin: ethyl, benzyl and N,N-diethylglycolamide ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats.
Cao F; Guo JX; Ping QN; Liao ZG
Eur J Pharm Sci; 2006 Dec; 29(5):385-93. PubMed ID: 16997537
[TBL] [Abstract][Full Text] [Related]
4. [Ester prodrug of scutellarin: synthesis, physicochemical property and degradation].
Cao F; Guo JX; Ping QN; Shao Y; Liang J
Yao Xue Xue Bao; 2006 Jul; 41(7):595-602. PubMed ID: 17007349
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics and metabolites of scutellarin in normal and model rats].
Gao HM; Wang ZM; Tian J
Yao Xue Xue Bao; 2005 Nov; 40(11):1024-7. PubMed ID: 16499088
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
Huang JM; Weng WY; Huang XB; Ji YH; Chen E
Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
[TBL] [Abstract][Full Text] [Related]
7. [Study on the pharmacokinetics of scutellarin in dogs].
Jiang XH; Li SH; Lan K; Yang JY; Zhou J
Yao Xue Xue Bao; 2003 May; 38(5):371-3. PubMed ID: 12958843
[TBL] [Abstract][Full Text] [Related]
8. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC.
Huang J; Li N; Yu Y; Weng W; Huang X
J Pharm Biomed Anal; 2006 Feb; 40(2):465-71. PubMed ID: 16181763
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration.
Chen X; Cui L; Duan X; Ma B; Zhong D
Drug Metab Dispos; 2006 Aug; 34(8):1345-52. PubMed ID: 16714374
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of scutellarin and tetrahydropalmatine of Deng-yan granule in rat plasma by UFLC-MS/MS and its application to a pharmacokinetic study.
Zhang X; Guan J; Zhu H; Niu T
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():126-32. PubMed ID: 25289789
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.
Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH
Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133
[TBL] [Abstract][Full Text] [Related]
12. Metabolism profile of scutellarin in urine following oral administration to rats by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry.
Liu Q; Shi Y; Wang Y; Lu J; Cong W; Luo G; Wang Y
Talanta; 2009 Nov; 80(1):84-91. PubMed ID: 19782195
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction between scutellarin and valsartan in rats.
Cui MY; Tian CC; Ju AX; Zhang CT; Li QH
Yao Xue Xue Bao; 2013 Apr; 48(4):541-6. PubMed ID: 23833943
[TBL] [Abstract][Full Text] [Related]
14. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics.
Hao X; Cheng G; Sun J; Zou M; Yu J; Zhang S; Cui F
J Pharm Biomed Anal; 2005 Jun; 38(2):360-3. PubMed ID: 15925232
[TBL] [Abstract][Full Text] [Related]
15. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.
Hao X; Cheng G; Yu JE; He Y; An F; Sun J; Cui F
Pharmazie; 2005 Jun; 60(6):477-8. PubMed ID: 15997843
[TBL] [Abstract][Full Text] [Related]
16. Scutellarin benzyl ester partially secured the ischemic injury by its anti-apoptosis mechanism in cardiomyocytes of neonatal rats.
Dai H; Gu J; Li LZ; Yang LM; Liu H; Li JY
Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):1014-21. PubMed ID: 21906527
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of four flavones of Glycyrrhiza in rat plasma using HPLC-MS.
Wu YP; Meng XS; Bao YR; Wang S
J Ethnopharmacol; 2013 Jun; 148(1):266-70. PubMed ID: 23643543
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic Comparison of Scutellarin and Paeoniflorin in Sham-Operated and Middle Cerebral Artery Occlusion Ischemia and Reperfusion Injury Rats after Intravenous Administration of Xin-Shao Formula.
Li Y; Lu Y; Hu J; Gong Z; Yang W; Wang A; Zheng J; Liu T; Chen T; Hu J; Mi L; Li Y; Lan Y; Wang Y
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617986
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
Shi S; Wu J; Dai W; Li C; Ge W
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
[TBL] [Abstract][Full Text] [Related]
20. Mrp2-related efflux of scutellarin in the intestinal absorption in rats.
Cao F; Zhang H; Guo J; Ping Q
Pharmazie; 2008 Jan; 63(1):75-80. PubMed ID: 18271309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
